MedTrace Logo

Prevalence of Comorbidities in Patients Undergoing Oncosurgeries at Tertiary Cancer Institute in North India.

NCT05038501 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2021-10-04

No results posted yet for this study

Summary

Investigators plan to study the prevalence of comorbidities in patients undergoing oncosurgeries

Conditions

  • Comorbidities and Coexisting Conditions

Interventions

OTHER

To study comorbidities in patients undergoing Oncosurgeries

In the Preoperative Anaesthesia checkup we will study prevalence of comorbidities as Coronary artery Disease, Hypertension, Diabetes Mellitus , Hypothyroidism and prior Corona Virus Infection in patients undergoing Oncosurgeries

Sponsors & Collaborators

  • Rajiv Gandhi Cancer Institute & Research Center, India

    lead OTHER

Principal Investigators

  • Anita Kulkarni, MD · Rajiv Gandhi Cancer Institute and RC , Delhi, INDIA

Eligibility

Min Age
35 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-01
Primary Completion
2021-08-31
Completion
2021-08-31

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05038501 on ClinicalTrials.gov